Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

The price of Apimeds Pharmaceuticals US, Inc (APUS) is 0.00001 and it was updated on 2025-05-09 01:49:33.

Currently Apimeds Pharmaceuticals US, Inc (APUS) is in undervalued.

Unlock
APUS Ratings Summary
APUS Quant Ranking